NCT04009980View on ClinicalTrials.gov

Long-term Retinal Changes After Topical Citicoline Administration in Patients With Mild Signs of Diabetic Retinopathy in Type 1 Diabetes Mellitus.

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 23, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

June 7, 2019

Conditions
Diabetic Retinopathy
Interventions
OTHER

OMK2 group

topical administration of OMk2 ophthalmic solution for 36 months three times/day

OTHER

Placebo group

topical administration of ophthalmic placebo solution for 36 months three times/day

Trial Locations (1)

00135

Fondazione G.B.Bietti, Roma

All Listed Sponsors
lead

Fondazione G.B. Bietti, IRCCS

OTHER

NCT04009980 - Long-term Retinal Changes After Topical Citicoline Administration in Patients With Mild Signs of Diabetic Retinopathy in Type 1 Diabetes Mellitus. | Biotech Hunter | Biotech Hunter